Early Life Stress and Depression: Molecular and Functional Imaging Approaches

Trial Profile

Early Life Stress and Depression: Molecular and Functional Imaging Approaches

Recruiting
Phase of Trial: Phase I

Latest Information Update: 31 Dec 2016

At a glance

  • Drugs Amisulpride (Primary)
  • Indications Major depressive disorder
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 16 Mar 2016 Planned End Date changed from 1 Nov 2015 to 1 Mar 2017, as reported by ClinicalTrials.gov.
    • 16 Mar 2016 Planned primary completion date changed from 1 Nov 2015 to 1 Mar 2017, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top